产品
编 号：F065876
分子式：C40H78N18O11
分子量：987.16
分子式：C40H78N18O11
分子量：987.16
产品类型
规格
价格
是否有货
结构图
CAS No: 119386-39-9
产品详情
生物活性：
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
体外研究：
Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and rate of activation of noradrenaline-evoked non-selective cation current (Icat) in rabbit portal vein myocytes.Myosin light chain kinase fragment 11-19 amide inhibits swelling-activated taurine transport with an IC50 value of 2.0 μM.Myosin light chain kinase fragment 11-19 amide (10 μM) inhibits β2-integrin-mediated adhesion in neutrophils treated with KT5720 (25 μM).
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
体外研究：
Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and rate of activation of noradrenaline-evoked non-selective cation current (Icat) in rabbit portal vein myocytes.Myosin light chain kinase fragment 11-19 amide inhibits swelling-activated taurine transport with an IC50 value of 2.0 μM.Myosin light chain kinase fragment 11-19 amide (10 μM) inhibits β2-integrin-mediated adhesion in neutrophils treated with KT5720 (25 μM).
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备